Seasonal Difference Observed in Systolic Blood Pressure
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 13, 2023 -- There is a seasonal effect on systolic blood pressure (SBP), according to a study presented at the American Heart Association Hypertension 2023 Scientific Sessions, held from Sept. 7 to 10 in Boston.
Robert B. Barrett, from the American Medical Association in Greenville, South Carolina, and colleagues assessed the influence of seasonal effects on average SBP. The analysis included 60,676 patients treated at one of six diverse health care organizations engaged in a quality improvement program.
The researchers found that SBP during winter months averaged 0.47 mm Hg higher than the yearly mean, which was associated with a significantly lower odds ratio for BP control (odds ratio, 0.92). In contrast, during the summer, average SBP was 0.92 mm Hg lower, with a higher likelihood of BP control (odds ratio, 1.10).
"Despite the smaller degree of systolic blood pressure variation in comparison to previous studies on seasonality in blood pressure, we were surprised to observe a large degree of change in blood pressure control between winter and summer months," Barrett said in a statement. "Individuals with hypertension or values near the range of hypertension may benefit from periodic blood pressure monitoring and improvements in physical activity and nutritional patterns during winter months to offset adverse effects from seasonal blood pressure changes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.